An Increase in Research Development and Healthcare Globally to Bolster the Growth of the Market

Published: Oct 2023

Global biobanks market is anticipated to grow at a CAGR of 10.1% during the forecast period (2023-2030). Biobanks are used to store biological samples for research purposes and are considered to be crucial for research development and healthcare through sample and data storage, analysis, and sharing. High investments in the R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, are driving the growth of the biobanks market. According to the National Institute of Health (NIH), in 2022, biobanks are the result of the combination of emerging novel technologies, well-cataloged human biological samples, and corresponding clinical and research data.

Browse the full report description of “Biobanks Market Size, Share & Trends Analysis Report by Equipment (Cryogenic Storage Systems, Refrigerators, Ice Machines, Freezers, Alarm Monitoring Systems, and Others), by Sample Type (Human Fluid, Cell, Human Tissue, and Organ, Nucleic Acids, and Other), and by Application (Therapeutic, Regenerative Medicine, Drug Discovery and Other), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/biobanks-market

By analyzing tissue samples, researchers can gain a better understanding of how diseases develop and progress, and they can identify potential targets for new treatments. For instance, in January 2023, Hamad Medical Corp and Qatar BioBank launched a tissue biobank. Tissue biobanking allows researchers to study diseases and health conditions at the cellular and molecular levels. By providing researchers with access to high-quality tissue samples, tissue biobanks support the development of new therapies and diagnostic tests that can benefit patients.

Biobank resource has created an unparalleled opportunity for medical research there have been some limitations with collating, storing, and accessing data at this scale. The new cloud-based platform removes these barriers and accelerates both the speed and scale of health-related research. For instance, in September 2021, UK Biobank, a large-scale biomedical database, and research resource, launched a uniquely powerful and innovative research platform that allows approved researchers to access and analyze the entire UK Biobank database securely, in the cloud, from anywhere in the globe.

The biobank study generates longitudinal physiological data from the samples collected and connected to other metadata to gain insights about changes in health status and understand the differences between pets that are healthy as they age and pets that develop diseases. For instance, in June 2022, Mars Petcare Biobank launched a pet biobank to drive breakthroughs in disease diagnosis & prevention. An unprecedented scientific initiative designed to improve understanding of pet health and disease, and help scientists and veterinarians innovate individualized healthcare for pets.

Market Coverage

The market number available for – 2022-2030

Base year- 2022

Forecast period- 2023-2030

Segment Covered- 

o By Equipment

o By Sample Type

o By Application

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Becton, Dickinson and Company, VWR International, LLC, Hamilton Company, IC Biomedical, LLC, Taylor-Wharton International LLC, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., and others

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

Who is the leader in the market?

How are players addressing challenges to sustain growth?

Where is the investment opportunity?

Global Biobanks Market Report Segment

By Equipment

  • Cryogenic Storage Systems
  • Refrigerators
  • Ice Machines
  • Freezers
  • Alarm Monitoring Systems
  • Other (Automated liquid handler)

By Sample Type 

  • Human Fluid (Blood, Serum, Plasma, Urine, Saliva, Spinal Fluid, and Other)
  • Cell (Bone Marrow Cells, Peripheral Blood Mononuclear Cells, and Others)
  • Human Tissue and Organ (End-Arterectomy Specimens)
  • Nucleic Acids (DNA/RNA/mDNA/microRNA)
  • Other

By Application

  • Therapeutics 
  • Regenerative Medicine
  • Drug Discovery
  • Other 

Global Biobanks Market Report Segment by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa


To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biobanks-market